2023 Q1 Form 10-Q Financial Statement

#000121390023021010 Filed on March 17, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $6.983M $6.915M
YoY Change 0.98% 30.13%
Cost Of Revenue $632.0K $342.0K
YoY Change 84.8% 9.27%
Gross Profit $6.351M $6.573M
YoY Change -3.38% 31.43%
Gross Profit Margin 90.95% 95.05%
Selling, General & Admin $5.871M $3.106M
YoY Change 89.02% 43.86%
% of Gross Profit 92.44% 47.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $815.0K $360.0K
YoY Change 126.39% 11.11%
% of Gross Profit 12.83% 5.48%
Operating Expenses $5.871M $3.466M
YoY Change 69.39% 39.59%
Operating Profit $1.458M $3.107M
YoY Change -53.07% 23.39%
Interest Expense $2.030M -$71.00K
YoY Change -2959.15% -189.87%
% of Operating Profit 139.23% -2.29%
Other Income/Expense, Net $39.00K
YoY Change
Pretax Income $1.695M $3.036M
YoY Change -44.17% 16.9%
Income Tax $89.00K $711.0K
% Of Pretax Income 5.25% 23.42%
Net Earnings $1.606M $2.325M
YoY Change -30.92% 2.06%
Net Earnings / Revenue 23.0% 33.62%
Basic Earnings Per Share $0.11 $0.16
Diluted Earnings Per Share $0.11 $155.3K
COMMON SHARES
Basic Shares Outstanding 14.09M shares 14.30M shares
Diluted Shares Outstanding 14.26M shares 14.97M shares

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.46M $30.02M
YoY Change -41.83% 120.58%
Cash & Equivalents $17.46M $30.02M
Short-Term Investments
Other Short-Term Assets $1.334M $393.0K
YoY Change 239.44% 50.57%
Inventory
Prepaid Expenses $1.334M
Receivables $2.788M $3.241M
Other Receivables $0.00 $0.00
Total Short-Term Assets $21.58M $33.65M
YoY Change -35.87% 100.57%
LONG-TERM ASSETS
Property, Plant & Equipment $1.933M $1.965M
YoY Change -1.63% -22.27%
Goodwill $10.72M
YoY Change
Intangibles $19.87M
YoY Change
Long-Term Investments
YoY Change
Other Assets $326.0K $650.0K
YoY Change -49.85% 330.46%
Total Long-Term Assets $33.67M $11.33M
YoY Change 197.14% 126.26%
TOTAL ASSETS
Total Short-Term Assets $21.58M $33.65M
Total Long-Term Assets $33.67M $11.33M
Total Assets $55.25M $44.98M
YoY Change 22.83% 106.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.381M $417.0K
YoY Change 231.18% 51.64%
Accrued Expenses $3.174M $2.365M
YoY Change 34.21% 74.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $7.360M $6.847M
YoY Change 7.49% 89.72%
LONG-TERM LIABILITIES
Long-Term Debt $1.983M $0.00
YoY Change -100.0%
Other Long-Term Liabilities $96.00K
YoY Change
Total Long-Term Liabilities $1.983M $96.00K
YoY Change 1965.63% -55.96%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.360M $6.847M
Total Long-Term Liabilities $1.983M $96.00K
Total Liabilities $9.343M $6.943M
YoY Change 34.57% 81.42%
SHAREHOLDERS EQUITY
Retained Earnings $3.597M
YoY Change
Common Stock $5.000K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.323M
YoY Change
Treasury Stock Shares 522.0K shares
Shareholders Equity $45.91M $38.04M
YoY Change
Total Liabilities & Shareholders Equity $55.25M $44.98M
YoY Change 22.83% 106.48%

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $1.606M $2.325M
YoY Change -30.92% 2.06%
Depreciation, Depletion And Amortization $815.0K $360.0K
YoY Change 126.39% 11.11%
Cash From Operating Activities $39.00K $2.985M
YoY Change -98.69% 31.27%
INVESTING ACTIVITIES
Capital Expenditures $372.0K -$135.0K
YoY Change -375.56% -27.42%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$372.0K -$135.0K
YoY Change 175.56% -27.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $7.000K
YoY Change -99.87%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -679.0K 7.000K
YoY Change -9800.0% -99.86%
NET CHANGE
Cash From Operating Activities 39.00K 2.985M
Cash From Investing Activities -372.0K -135.0K
Cash From Financing Activities -679.0K 7.000K
Net Change In Cash -1.012M 2.857M
YoY Change -135.42% -60.37%
FREE CASH FLOW
Cash From Operating Activities $39.00K $2.985M
Capital Expenditures $372.0K -$135.0K
Free Cash Flow -$333.0K $3.120M
YoY Change -110.67% 26.83%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-01-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei City Area Code
CityAreaCode
(330)
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-37782
dei Entity Registrant Name
EntityRegistrantName
ZEDGE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-3199071
dei Entity Address Address Line1
EntityAddressAddressLine1
1178 Broadway
dei Entity Address Address Line2
EntityAddressAddressLine2
3rd Floor #1450
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
dei Local Phone Number
LocalPhoneNumber
577-3424
dei Security12b Title
Security12bTitle
Class B common stock, par value $.01 per share
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Trading Symbol
TradingSymbol
ZDGE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 us-gaap Cash
Cash
17459000 usd
CY2022Q3 us-gaap Cash
Cash
17085000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2788000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2411000 usd
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1334000 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
396000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
21581000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
19892000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1933000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1660000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
19866000 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
21025000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
10716000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
10788000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
828000 usd
CY2022Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
861000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
326000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
400000 usd
CY2023Q1 us-gaap Assets
Assets
55250000 usd
CY2022Q3 us-gaap Assets
Assets
54626000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1381000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1180000 usd
CY2022Q3 us-gaap Loans Payable
LoansPayable
962000 usd
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
215000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3174000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2898000 usd
CY2023Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2805000 usd
CY2022Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3402000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7360000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8657000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1983000 usd
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1728000 usd
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
53000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
9343000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
10438000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2400000 shares
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2400000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q1 zdge Common Stock Value One
CommonStockValueOne
147000 usd
CY2022Q3 zdge Common Stock Value One
CommonStockValueOne
139000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
44979000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
43609000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1498000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1391000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3597000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2160000 usd
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
522000 shares
CY2022Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
74000 shares
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1323000 usd
CY2022Q3 us-gaap Treasury Stock Value
TreasuryStockValue
334000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
45907000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
44188000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
55250000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
54626000 usd
CY2023Q1 us-gaap Revenues
Revenues
6983000 usd
CY2022Q1 us-gaap Revenues
Revenues
6915000 usd
us-gaap Revenues
Revenues
13883000 usd
us-gaap Revenues
Revenues
12943000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
632000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
342000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
1264000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
652000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5871000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3106000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
11697000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5838000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
815000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
360000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1608000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
758000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1793000 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1943000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1458000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3107000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1257000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5695000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
77000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
112000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
27000 usd
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
160000 usd
CY2022Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-85000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
84000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-95000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1695000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3036000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1453000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5627000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
89000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
711000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1247000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1606000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2325000 usd
us-gaap Net Income Loss
NetIncomeLoss
1437000 usd
us-gaap Net Income Loss
NetIncomeLoss
4380000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-152000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
222000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
107000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
80000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
152000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-222000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-107000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-80000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1758000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2103000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1330000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4300000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.1
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.1
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14087000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14297000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14208000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14289000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14259000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14971000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14440000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15007000 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
44188000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
590000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-310000 usd
CY2022Q4 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-259000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-169000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
44040000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
743000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-679000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
45000 usd
CY2023Q1 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
152000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
1606000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
45907000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
33155000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
319000 usd
CY2021Q4 us-gaap Stock Issued During Period Value Treasury Stock Reissued
StockIssuedDuringPeriodValueTreasuryStockReissued
-232000 usd
CY2021Q4 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
142000 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
2055000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
35439000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
7000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
446000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
43000 usd
CY2022Q1 us-gaap Temporary Equity Foreign Currency Translation Adjustments
TemporaryEquityForeignCurrencyTranslationAdjustments
-222000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
2325000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
38038000 usd
us-gaap Net Income Loss
NetIncomeLoss
1437000 usd
us-gaap Net Income Loss
NetIncomeLoss
4380000 usd
us-gaap Depreciation
Depreciation
30000 usd
us-gaap Depreciation
Depreciation
23000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1158000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
224000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
420000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
511000 usd
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
1000 usd
zdge Loan Forgiveness
LoanForgiveness
-1943000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1378000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
808000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
33000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-50000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
377000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
741000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
938000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
244000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-22000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
497000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
806000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-597000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-39000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1121000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
5679000 usd
zdge Investment In Private Company
InvestmentInPrivateCompany
962000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
668000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
305000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
53000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1683000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-323000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
2000000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
18000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
7000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
989000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
232000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
993000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-225000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-57000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-23000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
374000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5108000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17085000 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24908000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17459000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
30016000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
711000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
309000 usd
us-gaap Interest Paid Net
InterestPaidNet
31000 usd
zdge Escrow Fund
EscrowFund
4776000 usd
zdge Due To Seller
DueToSeller
1923000 usd
us-gaap Legal Fees
LegalFees
12000 usd
us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
6711000 usd
us-gaap Stock Issued1
StockIssued1
45000 usd
CY2022 zdge Deferred Revenue Balance
DeferredRevenueBalance
1700000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
191663 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the Company’s unaudited condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, as well as related disclosure of contingent assets and liabilities. Actual results could differ materially from the Company’s estimates due to risks and uncertainties, including uncertainty in the current economic environment due to various global events. To the extent that there are material differences between these estimates and actual results, the Company’s financial condition or operating results will be affected. The Company bases its estimates on past experience and other assumptions that the Company believes are reasonable under the circumstances, and the Company evaluates these estimates on an ongoing basis.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 21.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1 us-gaap Revenues
Revenues
6983000 usd
CY2022Q1 us-gaap Revenues
Revenues
6915000 usd
us-gaap Revenues
Revenues
13883000 usd
us-gaap Revenues
Revenues
12943000 usd
CY2022Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
2000000 usd
zdge Deferred Revenue Balance
DeferredRevenueBalance
1200000 usd
zdge Unsatisfied Performance Obligations Description
UnsatisfiedPerformanceObligationsDescription
The Company records deferred revenues related to the unsatisfied performance obligations with respect to subscription revenue. The Company’s deferred revenue balance related to paid subscriptions was approximately $1.4 million related to approximately 654,000 active subscribers, and approximately $1.5 million, related to approximately 692,000 active subscribers as of January 31, 2023 and July 31, 2022, respectively. The amount of revenue related to subscribers recognized in the six months ended January 31, 2023 that was included in the deferred balance at July 31, 2022 was $1.1 million. 
CY2023Q1 us-gaap Foreign Currency Fair Value Hedge Asset At Fair Value
ForeignCurrencyFairValueHedgeAssetAtFairValue
86000 usd
CY2022Q3 us-gaap Shortterm Debt Fair Value
ShorttermDebtFairValue
215000 usd
CY2022Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1728000 usd
CY2022Q3 us-gaap Foreign Currency Fair Value Hedge Liability At Fair Value
ForeignCurrencyFairValueHedgeLiabilityAtFairValue
141000 usd
CY2023Q1 us-gaap Contingent Consideration Classified As Equity Fair Value Disclosure
ContingentConsiderationClassifiedAsEquityFairValueDisclosure
1943000000 usd
zdge Description Of Location Of Foreign Currency Derivatives On Balance Sheet1
DescriptionOfLocationOfForeignCurrencyDerivativesOnBalanceSheet1
Other current assets
CY2023Q1 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
86000 usd
zdge Description Of Location Of Foreign Currency Derivatives On Balance Sheet Liabilities
DescriptionOfLocationOfForeignCurrencyDerivativesOnBalanceSheetLiabilities
Accrued expenses and other current liabilities
CY2022Q3 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
141000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
17000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
232000 usd
CY2022Q4 us-gaap Stock Option Exercise Price Increase
StockOptionExercisePriceIncrease
2.27
zdge Statement Of Comprehensive Loss Location
StatementOfComprehensiveLossLocation
Net gain (loss) resulting from foreign exchange transactions
CY2023Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
185000 usd
CY2022Q1 us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-127000 usd
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
64000 usd
us-gaap Gain Loss On Foreign Currency Derivative Instruments Not Designated As Hedging Instruments
GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments
-117000 usd
CY2023Q1 zdge Preliminary Purchase Price
PreliminaryPurchasePrice
5900000 usd
CY2023Q1 us-gaap Business Combination Assets Arising From Contingencies Amount Recognized Other Than At Fair Value
BusinessCombinationAssetsArisingFromContingenciesAmountRecognizedOtherThanAtFairValue
0 usd
zdge Business Combination And Assets Acquisition Description
BusinessCombinationAndAssetsAcquisitionDescription
the Company has committed to a retention pool of $4 million in cash and 626,242 shares of the Company Class B common stock (the number of shares was determined based on a value of $4 million or $6.39 per share which was the volume weighted average closing prices of the Class B common stock on the NYSE American Exchange for the thirty trading days ended April 12, 2022) for GuruShots’ founders and employees that will be payable or vest, as applicable, over three years from April 1, 2022 based on the beneficiaries thereof remaining employed by the Company or a subsidiary.
us-gaap Asset Acquisition Consideration Transferred
AssetAcquisitionConsiderationTransferred
15242000 usd
us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
2700000 usd
zdge Cash Deducted From Purchase Price And Contirbuted To Guru Shots Working Capital
CashDeductedFromPurchasePriceAndContirbutedToGuruShotsWorkingCapital
58000 usd
zdge Fair Value Of Contingent Consideration To Be Achieved At Year1
FairValueOfContingentConsiderationToBeAchievedAtYear1
3396000 usd
zdge Fair Value Of Contingent Consideration To Be Achieved At Year2
FairValueOfContingentConsiderationToBeAchievedAtYear2
2508000 usd
zdge Fair Value Of Total Consideration Transferred
FairValueOfTotalConsiderationTransferred
23904000 usd
zdge Total Purchase Price Net Of Cash Acquired
TotalPurchasePriceNetOfCashAcquired
23384000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
520000 usd
CY2023Q1 us-gaap Accounts Receivable From Securitization
AccountsReceivableFromSecuritization
282000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
145000 usd
CY2023Q1 us-gaap Property Plant And Equipment Other Net
PropertyPlantAndEquipmentOtherNet
17000 usd
us-gaap Additions To Other Assets Amount
AdditionsToOtherAssetsAmount
151000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1351000 usd
CY2023Q1 zdge Operating Lease Liabilities Current
OperatingLeaseLiabilitiesCurrent
53000 usd
CY2023Q1 zdge Operating Lease Liabilities Noncurrent
OperatingLeaseLiabilitiesNoncurrent
34000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
15320000 usd
CY2023Q1 us-gaap Goodwill Gross
GoodwillGross
8907000 usd
zdge Total Purchase Price
TotalPurchasePrice
23904000 usd
CY2023Q1 us-gaap Retention Payable
RetentionPayable
1100000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
15320000 usd
us-gaap Goodwill Subsequent Recognition Of Deferred Tax Asset
GoodwillSubsequentRecognitionOfDeferredTaxAsset
8900000 usd
CY2023Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
180000000 usd
CY2021Q3 us-gaap Customer Funds
CustomerFunds
4800000 usd
zdge Intangible Assets Estimated Useful Lives
IntangibleAssetsEstimatedUsefulLives
fifteen years
CY2023Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year One
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearOne
1158000 usd
CY2023Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Two
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearTwo
2315000 usd
CY2023Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Three
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearThree
2315000 usd
CY2023Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Four
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearFour
2315000 usd
CY2023Q1 us-gaap Present Value Of Future Insurance Profits Amortization Expense Year Five
PresentValueOfFutureInsuranceProfitsAmortizationExpenseYearFive
2315000 usd
CY2023Q1 zdge Present Value Of Future Insurance Profits Amortization Expense Therfore
PresentValueOfFutureInsuranceProfitsAmortizationExpenseTherfore
9449000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
19866000 usd
CY2023Q1 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
1200000 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
200000 usd
CY2022Q3 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
10788000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-72000 usd
CY2023Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
10716000 usd
CY2023Q1 us-gaap Accrued Vacation Current
AccruedVacationCurrent
646000 usd
CY2022Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
585000 usd
CY2023Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
39000 usd
CY2022Q3 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
169000 usd
CY2023Q1 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
225000 usd
CY2022Q3 us-gaap Accrued Payroll Taxes Current
AccruedPayrollTaxesCurrent
214000 usd
CY2023Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1654000 usd
CY2022Q3 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1084000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
166000 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
262000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
119000 usd
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
142000 usd
CY2022Q3 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
141000 usd
CY2023Q1 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
313000 usd
CY2022Q3 us-gaap Due To Affiliate Current
DueToAffiliateCurrent
301000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
12000 usd
CY2023Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
3174000 usd
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
2898000 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y
zdge Share Based Compensation Arrangement By Share Based Payment Award Options Restricted Stock Units Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsRestrictedStockUnitsContractualTerm
P3Y
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
788000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
489000 usd
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.611 pure
us-gaap Share Based Compensation
ShareBasedCompensation
1378000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
808000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Percentage Of Outstanding Stock Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
0.705 pure
zdge Incremental Stock Based Compensation
IncrementalStockBasedCompensation
87000 usd
us-gaap Other Expenses
OtherExpenses
43000 usd
zdge Recognized Expenses
RecognizedExpenses
44000 usd
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
14087000 shares
CY2022Q1 us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
14297000 shares
us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
14208000 shares
us-gaap Weighted Average Limited Partnership Units Outstanding
WeightedAverageLimitedPartnershipUnitsOutstanding
14289000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
163000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
584000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
223000 shares
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
624000 shares
CY2023Q1 zdge Nonvested Restricted Class B Common Stock
NonvestedRestrictedClassBCommonStock
4000 shares
CY2022Q1 zdge Nonvested Restricted Class B Common Stock
NonvestedRestrictedClassBCommonStock
68000 shares
zdge Nonvested Restricted Class B Common Stock
NonvestedRestrictedClassBCommonStock
5000 shares
zdge Nonvested Restricted Class B Common Stock
NonvestedRestrictedClassBCommonStock
72000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
5000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000 shares
CY2023Q1 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
14259000 shares
CY2022Q1 us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
14971000 shares
us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
14440000 shares
us-gaap Weighted Average Limited Partnership Units Outstanding Diluted
WeightedAverageLimitedPartnershipUnitsOutstandingDiluted
15007000 shares
CY2023Q1 us-gaap Stock Dividends Shares
StockDividendsShares
227000 shares
CY2022Q1 us-gaap Stock Dividends Shares
StockDividendsShares
65000 shares
us-gaap Stock Dividends Shares
StockDividendsShares
106000 shares
us-gaap Stock Dividends Shares
StockDividendsShares
57000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
617000 shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
617000 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
228000 shares
CY2022Q1 us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
289000 shares
us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
228000 shares
us-gaap Stock Issued During Period Shares Conversion Of Units
StockIssuedDuringPeriodSharesConversionOfUnits
230000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1072000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
354000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
951000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
287000 shares
CY2023Q1 us-gaap Other Commitment Due In Second And Third Year
OtherCommitmentDueInSecondAndThirdYear
4000000 usd
CY2016Q3 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
2500000 usd
CY2020Q3 us-gaap Debt Instrument Redemption Price Percentage Of Principal Amount Redeemed
DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed
0.035 pure
CY2020Q3 zdge Prime Rate Plus Percentage
PrimeRatePlusPercentage
0.0125 pure
us-gaap Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
Previously the interest rate was capped at 5.0%. Interest was payable monthly and all outstanding principal and any accrued and unpaid interest was due on the maturity date of September 26, 2022.
us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
10000000 usd
CY2022Q4 us-gaap Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
On October 28, 2022, the Company entered into an Amended and Restated Loan and Security Agreement (“Amended Loan Agreement”) with Western Alliance Bank. Pursuant to the Amended Loan Agreement, Western Alliance Bank agreed to provide the Company with a new term loan facility in the maximum principal amount of $7 million for a four-year term and a $4 million revolving credit facility for a two-year term.
CY2023Q1 us-gaap Line Of Credit Facility Capacity Available For Trade Purchases
LineOfCreditFacilityCapacityAvailableForTradePurchases
2000000 usd
CY2022Q4 us-gaap Line Of Credit Facility Periodic Payment Principal
LineOfCreditFacilityPeriodicPaymentPrincipal
2000000 usd
CY2022Q4 us-gaap Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
5000000 usd
us-gaap Line Of Credit Facility Annual Principal Payment
LineOfCreditFacilityAnnualPrincipalPayment
1000000 usd
CY2023Q1 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.10 pure
zdge Balance Of Maximum Debts
BalanceOfMaximumDebts
To be agreed upon
CY2016Q4 us-gaap Line Of Credit Facility Borrowing Capacity Description
LineOfCreditFacilityBorrowingCapacityDescription
As of November 16, 2016, the Company entered into a Foreign Exchange Agreement with Western Alliance Bank to allow the Company to enter into foreign exchange contracts not to exceed $5.0 million in the aggregate at any point in time under its revolving credit facility. This limit was raised to approximately $7.5 million pursuant to the Loan and Security Modification Agreement dated May 30, 2018. The available borrowing under the revolving credit facility is reduced by an applicable foreign exchange reserve percentage as determined by Western Alliance Bank, in its reasonable discretion from time to time, which was set at 10% of the nominal amount of the foreign exchange contracts in effect at the relevant time.
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
usd
zdge Loan Forgiveness
LoanForgiveness
usd
zdge Investment In Private Company
InvestmentInPrivateCompany
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Revenues
Revenues
6983000 usd
CY2022Q1 us-gaap Revenues
Revenues
6915000 usd
CY2022Q1 zdge Change Total Revenue Percentage
ChangeTotalRevenuePercentage
0.01 pure
us-gaap Revenues
Revenues
13883000 usd
us-gaap Revenues
Revenues
12943000 usd
zdge Change Total Revenue Percentage
ChangeTotalRevenuePercentage
0.073 pure
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1458000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
3107000 usd
CY2022Q1 zdge Change Of Segment Incomeloss From Operation
ChangeOfSegmentIncomelossFromOperation
-0.531 pure
us-gaap Operating Income Loss
OperatingIncomeLoss
1257000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
5695000 usd
zdge Change Of Segment Incomeloss From Operation
ChangeOfSegmentIncomelossFromOperation
-0.779 pure
CY2023Q1 zdge United States Assets
UnitedStatesAssets
7471000 usd
CY2023Q1 zdge Foreign Long Lived Assets Net
ForeignLongLivedAssetsNet
14604000 usd
CY2023Q1 zdge Long Lived Assets Net Total
LongLivedAssetsNetTotal
22075000 usd
CY2022Q3 zdge United States Assets
UnitedStatesAssets
7818000 usd
CY2022Q3 zdge Foreign Long Lived Assets Net
ForeignLongLivedAssetsNet
15217000 usd
CY2022Q3 zdge Long Lived Assets Net Total
LongLivedAssetsNetTotal
23035000 usd
CY2023Q1 zdge United States Total Assets
UnitedStatesTotalAssets
26896000 usd
CY2023Q1 zdge Foreign Assets
ForeignAssets
28354000 usd
CY2023Q1 zdge Assets Total
AssetsTotal
55250000 usd
CY2022Q3 zdge United States Total Assets
UnitedStatesTotalAssets
26229000 usd
CY2022Q3 zdge Foreign Assets
ForeignAssets
28397000 usd
CY2022Q3 zdge Assets Total
AssetsTotal
54626000 usd
us-gaap Escrow Deposit Disbursements Related To Property Acquisition1
EscrowDepositDisbursementsRelatedToPropertyAcquisition1
usd
us-gaap Stock Issued1
StockIssued1
usd
CY2022Q3 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
usd
CY2023Q1 us-gaap Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
usd
CY2023Q1 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
usd
CY2022Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
usd
CY2022Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
shares
us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
shares
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
130000000 usd
CY2022Q3 us-gaap Other Restricted Assets
OtherRestrictedAssets
204000000 usd
CY2023Q1 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
3500000 usd
CY2023Q1 us-gaap Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income
BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome
2700000000 usd
CY2023Q1 us-gaap Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income
BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome
27064125000 nok
CY2023Q1 us-gaap Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income
BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome
2700000000 usd
CY2023Q1 us-gaap Business Acquisitions Purchase Price Allocation Year Of Acquisition Net Effect On Income
BusinessAcquisitionsPurchasePriceAllocationYearOfAcquisitionNetEffectOnIncome
2481077000 eur
CY2023Q1 us-gaap Loans Payable
LoansPayable
usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
usd
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--07-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001667313

Files In Submission

Name View Source Status
0001213900-23-021010-index-headers.html Edgar Link pending
0001213900-23-021010-index.html Edgar Link pending
0001213900-23-021010.txt Edgar Link pending
0001213900-23-021010-xbrl.zip Edgar Link pending
f10q0123ex31-1_zedge.htm Edgar Link pending
f10q0123ex31-2_zedge.htm Edgar Link pending
f10q0123ex32-1_zedge.htm Edgar Link pending
f10q0123ex32-2_zedge.htm Edgar Link pending
f10q0123_zedgeinc.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
image_003.jpg Edgar Link pending
image_004.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10q0123_zedgeinc_htm.xml Edgar Link completed
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zdge-20230131.xsd Edgar Link pending
zdge-20230131_cal.xml Edgar Link unprocessable
zdge-20230131_lab.xml Edgar Link unprocessable
zdge-20230131_def.xml Edgar Link unprocessable
zdge-20230131_pre.xml Edgar Link unprocessable